Psilocybin in treatment-resistant depression

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518654-16-01

Enrollment

Registered

2025-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment-resistant depression

Brief summary

Severity of depression as measured with the Beck Depression Inventory II 1 week after a 4 weeks of administration of psilocybin

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Severity of depression as measured with the Beck Depression Inventory II 1 week after a 4 weeks of administration of psilocybin	—

Countries

Austria

Outcome results